98%
921
2 minutes
20
There is a continued increase in demand for novel bone grafting substitutes to reduce reliance on and address challenges associated with allograft and autograft bone grafts. Current synthetic bone grafting substitutes exhibit low mechanical strength and bioactivity, which has inspired the development of novel grafting materials. Accelerating the translation of new bone graft substitutes requires workflows for high-throughput fabrication and analysis of particle-containing models. This study utilized 3D sacrificial printing for the fabrication of reproducible, cellular scaffolds containing tricalcium phosphate (TCP), hydroxyapatite (HA), or natural coral particles. High-throughput analysis of the cellular scaffolds included quantifying cell metabolism, viability, and calcium consumption, as well as nondestructive analysis of collagen accumulation and destructive methods for assessing cell number and morphological changes. Both particle- and non-particle-containing inks sustained cell metabolism with low and decreasing cell death for 7 days post-printing. Collagen staining, scanning electron microscopy imaging, and calcium and collagen quantification suggested that, under osteogenic induction conditions, cells migrated to the surface of the scaffolds and formed a sheet of cells and a collagen-containing extracellular matrix, thereby indicating osteogenic differentiation. The workflow described herein enables the creation of models to study the osteogenic nature of new bone grafting substitute materials. High-throughput printing combined with non-destructive screening techniques resulted in reduced time, resources, and associated costs and could be applicable to a broader range of cell types.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12019730 | PMC |
http://dx.doi.org/10.1021/acsomega.4c10515 | DOI Listing |
Front Immunol
September 2025
Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
NSG-SGM3 humanized mouse models are well-suited for studying human immune physiology but are technically challenging and expensive. We previously characterized a simplified NSG-SGM3 mouse, engrafted with human donor CD34 hematopoietic stem cells without receiving prior bone marrow ablation or human secondary lymphoid tissue implantation, that still retains human mast cell- and basophil-dependent passive anaphylaxis responses. Its capacities for human antibody production and human B cell maturation, however, remain unknown.
View Article and Find Full Text PDFJ Exp Pharmacol
September 2025
Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Purpose: Acute graft-versus-host disease (aGVHD) is a significant cause of death in recipients of allogeneic hematopoietic stem cell transplantation. In this type of graft, the intestine is particularly affected, with the loss of intestinal barrier integrity playing a key role in its onset. In this scenario, the aim of the present research was to evaluate defibrotide, a heparin-like compound, marked for severe veno-occlusive disease, as an innovative therapeutic approach for restoring intestinal barrier integrity using an in vitro model and analyzing aGVHD patients' sera and clinical data.
View Article and Find Full Text PDFBlood Cell Ther
August 2025
Japanese Data Center for Hematopoietic Cell Transplantation (JDCHCT), Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.
[This corrects the article DOI: 10.31547/bct-2024-020.].
View Article and Find Full Text PDFBlood Cell Ther
August 2025
Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver, Canada.
Introduction: The impact of race on outcomes of allogeneic hematopoietic cell transplants (HCT) has long been a field of research. The Center for International Blood and Marrow Transplant Research (CIBMTR) studies have shown worse survival for Black and Hispanic patients within the first year after HCT, but rates evened out for one-year survivors. From our personal experience, we hypothesize that the outcomes of South Asians (age ≥ 45 years) receiving myeloablative conditioning (MAC) are also worse compared to other races.
View Article and Find Full Text PDFChron Respir Dis
September 2025
Department of Pulmonology, II.Medical Clinic and Polyclinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Case presentationDescription of a patient with a progressive destructive lung disease resembling pleuroparenchymal fibroelastosis, liver cirrhosis and bone marrow changes. Genetic workup identified a rare heterozygous coding variant in the (telomerase reverse transcriptase) gene c.472 C>T; p.
View Article and Find Full Text PDF